Dana N, Vaseghi G, haghjooy javanmard shaghayegh. PPAR γ agonist, pioglitazone, suppresses melanoma cancer in mice by inhibiting TLR4 signaling. J Pharm Pharm Sci [Internet]. 2019 Sep. 10 [cited 2024 May 5];22(1):418-23. Available from: https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/30626